Press releases 2020

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2020-12-01 15:00
News
IR
English
Corporate Information
Other Corporate Information
First patient in the European Heart Preservation study transplanted
2020-12-01 15:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Första patienten i den europeiska hjärtpreservationsstudien har blivit transplanterad
2020-11-20 08:30
News
IR
English
Corporate Information
Other Corporate Information
Publication in The Lancet shows better survival of transplanted kidneys after cold machine perfusion with oxygen
2020-11-20 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
The Lancet publikation visar på bättre överlevnad av transplanterade njurar efter kall maskinperfusion med tillsatt syrgas
2020-10-23 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
First in the world with products for all major solid organs
2020-10-23 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Först i världen med produkter inom samtliga stora organområden
2020-10-16 16:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2020-10-16 16:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2020-10-14 16:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Extraordinary General Meeting in XVIVO Perfusion
2020-10-14 16:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från extra bolagsstämma i XVIVO Perfusion
2020-10-01 18:00
News
IR
English
Corporate Action
M&A
XVIVO Perfusion completes the acquisition of Organ Assist B.V.
2020-10-01 18:00
News
IR
Swedish
Corporate Action
M&A
XVIVO Perfusion slutför förvärvet av Organ Assist B.V.
2020-09-30 08:45
News
IR
Swedish
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2020-09-30 08:45
News
IR
English
Corporate Information
Nomination Committee
Nomination committee of XVIVO Perfusion AB (publ)
2020-09-30 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Ökat antal aktier och röster i XVIVO Perfusion AB (publ)
2020-09-30 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Increased number of shares and votes in XVIVO Perfusion AB (publ)
2020-09-24 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO Perfusions teckningsoptionsprogram 2020/2022
2020-09-24 07:30
News
IR
English
Corporate Information
Other Corporate Information
XVIVO Perfusion’s warrant program 2020/2022
2020-09-23 23:04
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion has carried out a directed share issue of 2,118,640 shares at a subscription price of SEK 236 per share
2020-09-23 23:04
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion har genomfört en riktad nyemission av 2 118 640 aktier till en teckningskurs om 236 kronor per aktie
2020-09-23 17:31
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion avser att genomföra en riktad nyemission av aktier
2020-09-23 17:31
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion intends to carry out a directed issue of shares
2020-09-23 17:30
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion to acquire the Dutch medtech company Organ Assist and finances the acquisition through a private placement of new shares
2020-09-23 17:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion förvärvar det nederländska medicintekniska företaget Organ Assist och finansierar förvärvet genom en nyemission av aktier
2020-09-21 16:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Staff change
Changes in XVIVO Perfusion's Management Team
2020-09-21 16:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
Förändringar i XVIVO Perfusions ledningsgrupp
2020-09-11 16:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till extra bolagsstämma i XVIVO Perfusion AB (publ)
2020-09-11 16:15
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice to attend the Extraordinary General Meeting in XVIVO Perfusion AB (publ)
2020-09-09 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Första patienten i PrimECC-studien inkluderad
2020-09-09 07:30
News
IR
English
Corporate Information
Other Corporate Information
First patient in the PrimECC study included
2020-09-04 11:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO Perfusion stärker ledningsgruppen med ny Commercial Director och ny R&D Director
2020-09-04 11:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO Perfusion strengthens the management team with the addition of a new Commercial Director and R&D Director
2020-07-10 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
I startblocken inför studieuppstart för hjärtpreservation och PrimECC
2020-07-10 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
In the starting blocks for heart preservation and PrimECC trial
2020-07-02 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2020-07-02 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2020-06-12 16:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Hjärtpreservations-studien från Lund publicerad i Nature Communications
2020-06-12 16:30
News
IR
English
Corporate Information
Other Corporate Information
The study from Lund published in Nature Communications
2020-05-19 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
XPS™ säljs till en ledande lungtransplantationsklinik i Europa
2020-05-19 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
XPS™ sold to a leading lung transplant clinic in Europe
2020-04-28 18:30
News
IR
English
Regulatory
MAR
Corporate Information
Staff change
Magnus Nilsson hands over the baton to Dag Andersson as President and CEO of XVIVO Perfusion
2020-04-28 18:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Staff change
Magnus Nilsson lämnar över stafettpinnen till Dag Andersson som vd och koncernchef för XVIVO Perfusion
2020-04-24 15:40
News
IR
Swedish
Corporate Information
Staff change
XVIVO utnämner ny IP-chef och ny Medicinsk chef
2020-04-24 15:40
News
IR
Swedish
Corporate Information
Staff change
XVIVO appoints a new IP manager and a new Medical Director
2020-04-09 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q1
Strong cash flow despite the influence of Covid-19
2020-04-09 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q1
Starkt kassaflöde trots påverkan av Covid-19
2020-04-06 11:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport (uppdaterad länk)
2020-04-06 11:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report (link updated)
2020-04-02 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2020-04-02 07:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Conference call on Interim Report
2020-03-31 17:00
News
IR
Swedish
Regulatory
MAR
VPML
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2020-03-31 17:00
News
IR
English
Regulatory
MAR
VPML
Corporate Information
General meeting
Report of the AGM
Report from Annual general meeting of XVIVO Perfusion AB (publ)
2020-03-31 09:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
XPS™ såld till pediatrisk transplantationsklinik i Italien
2020-03-31 09:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
XPS™ sold to pediatric transplantation clinic in Italy
2020-03-25 10:50
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Valberedningen föreslår oförändrade styrelsearvoden – justerad version
2020-03-25 10:50
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
The Nomination Committee proposes unchanged Board remuneration -adjusted version
2020-03-25 10:15
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
The Nomination Committee proposes unchanged Board remuneration
2020-03-25 10:15
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Valberedningen föreslår oförändrade styrelsearvoden
2020-03-25 08:30
News
IR
English
Regulatory
MAR
VPML
Corporate Information
Financial calendar
XVIVO Perfusion advances the date for submission of the January-March 2020 interim report
2020-03-25 08:30
News
IR
Swedish
Regulatory
MAR
VPML
Corporate Information
Financial calendar
XVIVO Perfusion tidigarelägger datum för avlämnande av delårsrapport för Januari-Mars 2020
2020-03-18 08:30
News
IR
Swedish
Regulatory
VPML
Corporate Information
Other Corporate Information
Med anledning av Covid-19: XVIVO Perfusion AB:s årsstämma flyttas till ny adress och ytterligare försiktighetsåtgärder vidtas
2020-03-18 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
As a result of Covid-19: The Annual General Meeting of XVIVO Perfusion is moved to a new address and further precautions are taken
2020-03-18 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
COVID-19 EPIDEMINS PÅVERKAN PÅ XVIVO PERFUSION
2020-03-18 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
THE COVID-19 EFFECT ON XVIVO PERFUSION
2020-03-09 09:00
News
IR
English
Regulatory
VPML
Report
Annual
Annual Report 2019
2020-03-09 09:00
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2019
2020-02-24 23:45
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice to attend the Annual General Meeting of XVIVO Perfusion AB (publ)
2020-02-24 23:45
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2020-01-30 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Yearend
A historic year ended with a quarter of sales records
2020-01-30 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Yearend
Kvartal med försäljningsrekord avslutar ett historiskt år
2020-01-24 08:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké
2020-01-24 08:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2020-10-23 07:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
First in the world with products for all major solid organs
2020-10-23 07:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Först i världen med produkter inom samtliga stora organområden
2020-10-14 16:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Extraordinary General Meeting in XVIVO Perfusion
2020-10-14 16:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från extra bolagsstämma i XVIVO Perfusion
2020-09-30 08:30
News
IR
Swedish
Regulatory
LHFI
Corporate Action
Shares
Ökat antal aktier och röster i XVIVO Perfusion AB (publ)
2020-09-30 08:30
News
IR
English
Regulatory
LHFI
Corporate Action
Shares
Increased number of shares and votes in XVIVO Perfusion AB (publ)
2020-09-23 23:04
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion has carried out a directed share issue of 2,118,640 shares at a subscription price of SEK 236 per share
2020-09-23 23:04
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion har genomfört en riktad nyemission av 2 118 640 aktier till en teckningskurs om 236 kronor per aktie
2020-09-23 17:31
News
IR
Swedish
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion avser att genomföra en riktad nyemission av aktier
2020-09-23 17:31
News
IR
English
Regulatory
MAR
Corporate Action
Shares
Issuance
mfn-cus-disclaimer
XVIVO Perfusion intends to carry out a directed issue of shares
2020-09-23 17:30
News
IR
English
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion to acquire the Dutch medtech company Organ Assist and finances the acquisition through a private placement of new shares
2020-09-23 17:30
News
IR
Swedish
Regulatory
MAR
Corporate Action
M&A
mfn-cus-disclaimer
XVIVO Perfusion förvärvar det nederländska medicintekniska företaget Organ Assist och finansierar förvärvet genom en nyemission av aktier
2020-09-21 16:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Staff change
Changes in XVIVO Perfusion's Management Team
2020-09-21 16:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
Förändringar i XVIVO Perfusions ledningsgrupp
2020-09-11 16:15
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till extra bolagsstämma i XVIVO Perfusion AB (publ)
2020-09-11 16:15
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Notice to attend the Extraordinary General Meeting in XVIVO Perfusion AB (publ)
2020-07-10 07:30
News
IR
Swedish
Regulatory
MAR
VPML
Report
Interim
Q2
I startblocken inför studieuppstart för hjärtpreservation och PrimECC
2020-07-10 07:30
News
IR
English
Regulatory
MAR
VPML
Report
Interim
Q2
In the starting blocks for heart preservation and PrimECC trial
2020-04-28 18:30
News
IR
English
Regulatory
MAR
Corporate Information
Staff change
Magnus Nilsson hands over the baton to Dag Andersson as President and CEO of XVIVO Perfusion
2020-04-28 18:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Staff change
Magnus Nilsson lämnar över stafettpinnen till Dag Andersson som vd och koncernchef för XVIVO Perfusion
Next